Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proton Pump Inhibitors (PPI) as a New Strategy for Therapy in Sepsis: Clinical Trial to Reduce Severity of Organ Failure and in Vitro Experiments to Search Specific Hallmarks in Monocytes From Septic Patients and to Characterize the Mechanism of Action of PPI

NCT03452865 is registered in ClinicalTrials.gov with Università Vita-Salute San Raffaele as lead sponsor.

NCT NCT03452865
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03452865 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proton Pump Inhibitors (PPI) as a New Strategy for Therapy in Sepsis: Clinical Trial to Reduce Severity of Organ Failure and in Vitro Experiments to Search Specific Hallmarks in Monocytes From Septic Patients and to Characterize the Mechanism of Action of PPI
Lead sponsor
Università Vita-Salute San Raffaele
Phase
Phase 3
Overall status
Completed
Start date
January 28, 2020
Completion date
August 21, 2023
Enrollment
300 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, septic shock